Summary The interferons are a group of naturally occuring proteins that inhibit the growth of tumours in vivo and many transformed cell lines in vitro. The mechanisms of action of interferon, however, remain unclear. The IFN induced inhibition of growth of many epithelial cancer cell lines is associated with changes Interferons are a family of secretory cellular proteins with a wide range of biological effects. In addition to their antiviral activity, IFNs inhibit growth of both normal and transformed cells (Balkwill et al., 1982; Bradley & Ruscetti, 1981 (Chakravarthy et al., 1991) . The purpose of the present study was to examine the effect of IFN on synthesis and stability of the EGFR protein and mRNA.
Interferons are a family of secretory cellular proteins with a wide range of biological effects. In addition to their antiviral activity, IFNs inhibit growth of both normal and transformed cells (Balkwill et al., 1982; Bradley & Ruscetti, 1981) . Although the inhibitory actions of IFNs on cell proliferation have been recognised for many years, the mechanisms underlying this effect have not yet been identified.
One hypothesis to explain IFNs antiproliferative activity suggests that IFN may modulate growth factor action. Inhibition of growth of several epithelial cell lines is associated with changes in binding of Epidermal Growth Factor (EGF) to its receptor. For example, Chang et al. (1986) have demonstrated that treatment of the squamous epithelial cell line A43 1 with IFN-y results in morphologic changes associated with cell differentiation. Death of A431 cells after exposure to IFN-y is associated with an increase in expression of 10 kb mRNA species for EGFR. This group further demonstrated (Bernstein et al., 1988) that IFN both inhibits the growth of a variety of squamous cell carcinoma cell lines, the majority of which normally overexpress EGFR mRNA, and elevates levels of EGF receptor mRNA. In contrast, Zoon et al. (1986) have demonstrated that IFN-a inhibits EGF-stimulated growth of MDBK cells, and reduces binding of EGF to its receptor. Nickloff and Mitra (1989) have noted that IFN-y inhibits growth of human keratinocytes and reduces the number of EGF binding sites. Generally, IFN's increase EGFR mRNA expression in cells expressing amplified levels of EGFR mRNA pre-treatment, and decrease expression in cells with normal levels of EGFR.
We have been studying the possible interaction between IFN and EGF in control of the growth of the MDA 468 breast tumour cell line. MDA 468 cells contain greatly amplified numbers of EGFR and five copies of the gene for EGFR. We have found that IFN-y inhibits the growth of this cell line. In contrast to studies by Bernstein et al. (1988) , we found this growth inhibition was associated with decreased binding of '25I-EGF to cell surface receptors due to a change in receptor number rather than affinity (Chakravarthy et al., 1991) . The purpose of the present study was to examine the effect of IFN on synthesis and stability of the EGFR protein and mRNA.
Materials and methods

Cell culture
The MDA 468 cell line (kindly provided by Dr Ron Buick, Ontario Cancer Institute) was derived from a human breast carcinoma (Filmus et al., 1985) . It was routinely cultured in L-15 medium (Gibco) supplemented with 10% foetal bovine serum (FBS) (Sigma, St Louis, MO). Cells were subcultured twice weekly by trypsinisation. All cells were used within 20 passages of the original stock.
Protein labelling and immunoprecipitation MDA 468 cells (6 x 105 total) were plated in 75 cm2 flasks in 50% DMEM, 50% F-12 medium with 10% calf-serum. Medium were aspirated, the cells rinsed with methionine-free RPMI (ABS, Columbia, MD) and incubated for 6 h with "5Smethionine (38 piCi ml-') (S.A. 1129 Ci mmol-') (New England Nuclear, Boston, MA) in 5ml methionine free RPMI. Cells were lysed in 1 ml of 50 mM Tris HCI, Triton X-100 (1% v/v), SDS (0.1% w/v), PMSF (1 mM), EDTA (1 mM) and leupeptin (1 ,Ag ml-') at room temperature. Cell lysates were centrifuged and duplicate aliquots of each lysate were standardised by trichloroacetic acid precipitation. The samples were then incubated with a monoclonal antibody to EGF receptor (antibody 528) (final concentration of 1.5 jig ml-') (Oncogene Science Inc, Mineola, NY) or a non-specific antibody of the same isotype and Protein-A Sepharose. Bound material was released by heating the complexes in SDS buffer for 2 min at 100°C. The samples were then analysed on 7.5% SDS polyacrylamide gels. Following electrophoresis, the gels were treated with Enhance (NEN) and dried. The gels were exposed to Kodak XAR-5 film and developed. Where indicated, the relative amounts of immunoprecipitated EGF receptor were quantitated by densitometric analysis of the autoradiograms using a LKB laser densitometer with peak integration. Radioactivity incorporated into bands on dried gels was also directly quantitated using a Betascope analyser (Betagen, Cambridge, MA).
RNA extraction and Northern blot analysis Total RNA was isolated from MDA 468 cells with guanidinium thiocyanate as described (Chirgwin et al., 1979) (Figure 1 ). To determine if this increase of EGFR protein in IFN treated cells was due to increased stability of the protein, we performed pulse-chase experiments as described (Bjorge & Kuldow, 1987) . MDA 468 cells were metabolically labelled with "Smethionine for 6 h. The culture medium containing the labelled methionine was replaced with medium containing unlabelled methionine (600 pg ml-'). At various times after addition of cold methionine, the cell monolayers were solubilised and the EGF receptor quantitatively immunoprecipitated and analysed by gel electrophoresis. The amount of labelled receptor remaining at various times of exposure was quantitated by determining the amount of radioactivity in the receptor band using a Betascope analyser. The amount of EGF in both control and IFN treated cells diminished slowly. Fifty-four per cent of the originally labelled receptor remained after 48 h in both control and IFN treated cells (Figure 2a and b) . In contrast, Bjorge and Kudlow (1987) (Figure 4) . Rehybridisation of the same blot with a probe for P-actin did not shown any variation in the levels of this mRNA.
To determine the kinetics of the effect of IFN-y on the expression of EGF receptor gene, MDA 468 cells were exposed to IFN-y at 500 1 ml1' for various periods of time. Samples of RNA from each of the time points were dotted onto nylon membranes and the blot was hybridised to the pE7 probe. The amount of hybridisation was quantitated by analysis on a Betascope. At 1 ( Figure 5 ) and 2 (data not shown) days of IFN treatment, the steady-state levels of EGFR mRNA were equal in control and IFN-treated cells. Increases were initially observed at 3 days of treatment (approximately 3-fold). After 5 days of treatment, the steadystate level of EGFR mRNA was increased 4-fold ( Figure 5 ).
The increases were due both to increases in EGFR mRNA with time in IFN-treated cells, and decreases in EGFR mRNA level in control cells (Hamburger et al., 1991) . Rizzino et al. (1988) have similarly noted that EGFR binding decreases in both normal and malignant cell lines as cell density increases.
We also analysed RNA obtained from MDA 468 cells treated for 4 days with increasing concentrations of IFN. Figure 6 shows that the level of EGF receptor mRNA increased progressively with increasing concentrations of IFN. As little as 10 U ml-' of IFN-y enhanced the expression of EGFR mRNA 1.9-fold. Maximal levels of EGF receptor nitrocellulose filters, and the filters were hybridised to a cDNA probe for the EGF receptor as described.
mRNA were reached at approximately 100 fi ml-' (Figure 6 ).
To determine if the increase in EGFR mRNA induced by IFN after 4 days was due to inactivation of labile repressor proteins, we examined the effects of cycloheximide on EGFR expression (Figure 7 ). Cycloheximide alone increased message accumulation in untreated MDA 468 cells as previously described by Clark et al. (1985) . Addition of cycloheximide to IFN-treated cells failed to inhibit the IFN-induced increase (Figure 7) . However, pre-treatment of cells with IFN-y prevented the cycloheximide induced increases.
We also examined the effect of IFN treatment on EGFR mRNA half life as described (Fernandez-Pol et al., 1987) . Cell were treated for 4 days with IFN-y, at which time EGF receptor transcipts levels were still increasing, yet elevated 3-4-fold above control levels. Cells were then treated with high dose Actinomycin D (5 ig ml1') to shut off all transcriptional activity. The survival of EGFR mRNA was determined at 0.5, 1, 2, and 3 h after the Actinomycin D chase on Figure 7 Effect of cycloheximide (CH) on induction of EGF receptor mRNA by interferon. Cells were treated with either IFN-y (500 t ml ') for 4 days, 10 jug ml-I CH for the last 4 h, or both, and total RNA isolated and analysed on Northern blots as described. Lane A, untreated cells; Lane B, CH; Lane C, IFN; Lane D, IFN +CH. (Balkwill et al., 1982 Zoon et al. (1986) have demonstrated that IFN-a inhibits the EGF-stimulated growth of MDBK cells by decreasing EGF binding to its cell surface receptor. Nickloff and Mitra (1989) (Chakravarthy et al., 1991) . A decrease in the number of receptors, rather than a change in receptor affinity was noted. The seemingly paradoxical increase of EGFR protein and mRNA remains to be explored, but is not unprecendented. Raymond et al. (1990) found that treatment of rat liver epithelial cells with retinoic acid decreases the level of EGF binding, but increases receptor biosynthesis and steady state levels of EGFR mRNA. The decreases in binding were due to a change in receptor affinity. In our system, it is likely that the secretion of EGF-competing substances may be blocking cell surface receptors. We have found that IFN treatment can increase the secretion of TGF-ac by these cells (data not shown). Similarly, Kumar and Mendelsohn (1990) have shown that treatment of A43 1 cells with IFN-y enhances expression of TGF-m. In addition, IFN-y inhibits growth of human keratinocytes, decreases EGF binding, and increases TGF-a production (Nickloff & Mitra, 1989 (Brachmann et al., 1989) . Increased secretion of TGF-o could also be responsible for the IFN-y induced stimulation of EGFR synthesis, as TGF-a enhances EGFR synthesis in the cell line (Bjorge et al., 1989) .
In the present study, IFN- (Sainsbury et al., 1987) . It has been assumed that increased numbers of EGF receptors results in an increased response to the mitogenic effect of EGF. However, the growth of many cell lines with very high numbers of EGF receptors (including MDA 468 and A431 cells) is inhibited by EGF. A simple correlation between the number of EGF receptors and mitogenic activity of EGF does not exist.
In summary, our results indicate that IFN-y enhanced expression of EGFR mRNA and protein in a human breast carcinoma cell line. These changes were accompanied by a decrease in cell growth. Our studies support a growing body of literature that indicates the importance of the interaction between interferon and growth factors in the regulation of cell growth.
